35 million shares to be issued by Yu Heng Pharmaceutical Co.,

Panorama May 27, Yu-Heng pharmaceutical Industry (002437) issued a letter of intent on the giant Tide information network in the evening of Thursday. The company plans to issue 35 million shares, issued after the total share capital of 140 million shares.　　The unit will be implemented on June 7 online, net purchase, and will be listed in Shenzhen stock market.　　This issue uses the network to the placing of the allocation of the object of the placing of the allocation and online to the social public investors in a combination of pricing issues, of which under the network issued no more than 7 million shares, accounting for the number of the issue of 20%, the number of online distribution for the total amount of this issue minus net　　According to the issue schedule, the time for this inquiry is May 31-June 2, the publication date of the announcement is June 4, the date of purchase and the payment date is June 7. Harbin Yu Heng Pharmaceutical Co., Ltd. 's main business for drug production and pharmaceutical sales agent. Drug production, the company's products are mainly prescription drugs, the company has a total of 40 drug registration approval, the main production of 23 kinds of products, covering orthopedic drugs, rheumatism drugs, anti-tumor drugs, digestive system medication, respiratory medication, cardio-cerebrovascular drugs, liver drugs, gynecological drugs and antibiotics and other fields.　　At present, the company subsidiary of the main agent Jingwei pharmaceutical sales of 18 different specifications of products, of which the national agent of drugs 16. This issue raises funds to be invested in GMP technical improvement projects and off-site expansion projects, the total investment of 429 million yuan. (Panorama net/Chen Danyong)